Global Connected Drug Delivery Devices Market Research Report - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2033)
Description
Definition and Scope:
Since the past decade, the healthcare industry has increasingly digitalized with the widespread adoption of connected devices in laboratories & hospitals, electronic health records (EHR), and tablets & smartphones to support healthcare professionals. Opportunely, the widespread accessibility of low-cost connectivity such as near-universal access to technologies such as smartphone and Bluetooth have opened the door to novel opportunities in the healthcare industry.
Connected drug delivery devices are the wireless connected and smart electronic devices that allow patient-administrated therapy. Primarily, these devices are equipped with a sensor that offers various features such as adherence trackers, dosing remainder, and patient education tools. Also, these devices are used for the treatment of various diseases such as multiple sclerosis, diabetes, liver & renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.
The current health crisis highlights the value of migrating some healthcare procedures beyond the confines of the hospital. In some areas, this is already well-developed, notably remote patient monitoring for chronic respiratory conditions and diabetes. Other areas are now playing catch-up; According to BSR, the global market for connected drug delivery devices (injectables and inhalation devices specifically) is projected to reach $ 1293.20 million by 2028 – that is to say a CAGR of over 25% from its $ 266.44 million value in 2021. This projected pace will however depend on a number of key stakeholders and their attitudes towards the development and adoption of these devices. Given the potential of increased digitalisation in improving the efficiency of health services, a careful examination of the healthcare landscape and the factors driving new forms of patient monitoring is constructive.
As the demand for chronic condition therapies grows, an increasing proportion of patients will self-manage and selfadminister in the home, otherwise acute services will be overwhelmed
Connected devices are a critical tool to deliver the data flows which allows clinicians to remotely monitor and manage patient conditions
As staff shortages grow and healthcare demand increases, home administration will accelerate in importance, amplifying the need for digital remote connectivity
Connected drug delivery designers are under pressure to create products that enable connectivity but also minimise wastage, especially of embedded electronics that use rareearth elements
Governments, payers, healthcare providers and pharmaceutical companies are also having to work closely together to establish interoperability data standards, as well as collaboratively mitigating the risk of data protection breaches in a world of connected healthcare devices
From our market research,although interconnected devices have become the development trend of the drug delivery devices market, the business model of connected drug delivery devices market is still in the exploratory stage in the specific commercialization process. every company involved in drug delivery devices either has a connected technology or is developing one. Clinical evidence for improved adherence exists, and evidence for other clinical benefits is mounting. The data infrastructure exists, although systems are not familiar to patients or healthcare professionals yet, and there are legal hurdles to overcome when transferring patient data between legal jurisdictions. Traditional business models have struggled, but innovative business models are progressing.
This report offers a comprehensive analysis of the global Connected Drug Delivery Devices market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Connected Drug Delivery Devices market.
Global Connected Drug Delivery Devices Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Connected Drug Delivery Devices market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Connected Drug Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Phillips Medisize
Bayer AG
Kindeva
Merck KGaA
Propeller Health
Sulzer Ltd
Biocorp Production SA
OPKO Health
Cohero Health
Elcam Medical
Teva Pharmaceutical Industries Ltd
Sagentia (Science Group)
Proteus Digital Health, Inc
FindAir
Market Segmentation by Type
Inhalation Devices
Injectable Devices
Others
Market Segmentation by Application
Multiple Sclerosis (MS)
Asthma and COPD
Insulin Injection
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Connected Drug Delivery Devices Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Since the past decade, the healthcare industry has increasingly digitalized with the widespread adoption of connected devices in laboratories & hospitals, electronic health records (EHR), and tablets & smartphones to support healthcare professionals. Opportunely, the widespread accessibility of low-cost connectivity such as near-universal access to technologies such as smartphone and Bluetooth have opened the door to novel opportunities in the healthcare industry.
Connected drug delivery devices are the wireless connected and smart electronic devices that allow patient-administrated therapy. Primarily, these devices are equipped with a sensor that offers various features such as adherence trackers, dosing remainder, and patient education tools. Also, these devices are used for the treatment of various diseases such as multiple sclerosis, diabetes, liver & renal transplant recipients, hepatitis C, hypertension, asthma, tuberculosis, and clinically isolated syndrome.
The current health crisis highlights the value of migrating some healthcare procedures beyond the confines of the hospital. In some areas, this is already well-developed, notably remote patient monitoring for chronic respiratory conditions and diabetes. Other areas are now playing catch-up; According to BSR, the global market for connected drug delivery devices (injectables and inhalation devices specifically) is projected to reach $ 1293.20 million by 2028 – that is to say a CAGR of over 25% from its $ 266.44 million value in 2021. This projected pace will however depend on a number of key stakeholders and their attitudes towards the development and adoption of these devices. Given the potential of increased digitalisation in improving the efficiency of health services, a careful examination of the healthcare landscape and the factors driving new forms of patient monitoring is constructive.
As the demand for chronic condition therapies grows, an increasing proportion of patients will self-manage and selfadminister in the home, otherwise acute services will be overwhelmed
Connected devices are a critical tool to deliver the data flows which allows clinicians to remotely monitor and manage patient conditions
As staff shortages grow and healthcare demand increases, home administration will accelerate in importance, amplifying the need for digital remote connectivity
Connected drug delivery designers are under pressure to create products that enable connectivity but also minimise wastage, especially of embedded electronics that use rareearth elements
Governments, payers, healthcare providers and pharmaceutical companies are also having to work closely together to establish interoperability data standards, as well as collaboratively mitigating the risk of data protection breaches in a world of connected healthcare devices
From our market research,although interconnected devices have become the development trend of the drug delivery devices market, the business model of connected drug delivery devices market is still in the exploratory stage in the specific commercialization process. every company involved in drug delivery devices either has a connected technology or is developing one. Clinical evidence for improved adherence exists, and evidence for other clinical benefits is mounting. The data infrastructure exists, although systems are not familiar to patients or healthcare professionals yet, and there are legal hurdles to overcome when transferring patient data between legal jurisdictions. Traditional business models have struggled, but innovative business models are progressing.
This report offers a comprehensive analysis of the global Connected Drug Delivery Devices market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.
Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Connected Drug Delivery Devices market.
Global Connected Drug Delivery Devices Market: Segmentation Analysis and Strategic Insights
This section of the report provides an in-depth segmentation analysis of the global Connected Drug Delivery Devices market. The market is segmented based on region (country), manufacturer, product type, and application. Segmentation enables a more precise understanding of market dynamics and facilitates targeted strategies across product development, marketing, and sales.
By breaking the market into meaningful subsets, stakeholders can better tailor their offerings to the specific needs of each segment—enhancing competitiveness and improving return on investment.
Global Connected Drug Delivery Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Phillips Medisize
Bayer AG
Kindeva
Merck KGaA
Propeller Health
Sulzer Ltd
Biocorp Production SA
OPKO Health
Cohero Health
Elcam Medical
Teva Pharmaceutical Industries Ltd
Sagentia (Science Group)
Proteus Digital Health, Inc
FindAir
Market Segmentation by Type
Inhalation Devices
Injectable Devices
Others
Market Segmentation by Application
Multiple Sclerosis (MS)
Asthma and COPD
Insulin Injection
Others
Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA
Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Connected Drug Delivery Devices Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 4: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapters 5–10: Regional Market Analysis
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 11: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 12: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapter 13: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 14: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 15: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.
Table of Contents
215 Pages
- 1 Introduction to Research & Analysis Reports
- 1.1 Connected Drug Delivery Devices Market Definition
- 1.2 Connected Drug Delivery Devices Market Segments
- 1.2.1 Segment by Type
- 1.2.2 Segment by Application
- 2 Executive Summary
- 2.1 Global Connected Drug Delivery Devices Market Size
- 2.2 Market Segmentation – by Type
- 2.3 Market Segmentation – by Application
- 2.4 Market Segmentation – by Geography
- 3 Key Market Trends, Opportunity, Drivers and Restraints
- 3.1 Key Takeway
- 3.2 Market Opportunities & Trends
- 3.3 Market Drivers
- 3.4 Market Restraints
- 3.5 Market Major Factor Assessment
- 4 Global Connected Drug Delivery Devices Market Competitive Landscape
- 4.1 Global Connected Drug Delivery Devices Sales by Manufacturers (2020-2025)
- 4.2 Global Connected Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
- 4.3 Connected Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 4.4 New Entrant and Capacity Expansion Plans
- 4.5 Mergers & Acquisitions
- 5 Global Connected Drug Delivery Devices Market by Region
- 5.1 Global Connected Drug Delivery Devices Market Size by Region
- 5.1.1 Global Connected Drug Delivery Devices Market Size by Region
- 5.1.2 Global Connected Drug Delivery Devices Market Size Market Share by Region
- 5.2 Global Connected Drug Delivery Devices Sales by Region
- 5.2.1 Global Connected Drug Delivery Devices Sales by Region
- 5.2.2 Global Connected Drug Delivery Devices Sales Market Share by Region
- 6 North America Market Overview
- 6.1 North America Connected Drug Delivery Devices Market Size by Country
- 6.1.1 USA Market Overview
- 6.1.2 Canada Market Overview
- 6.1.3 Mexico Market Overview
- 6.2 North America Connected Drug Delivery Devices Market Size by Type
- 6.3 North America Connected Drug Delivery Devices Market Size by Application
- 6.4 Top Players in North America Connected Drug Delivery Devices Market
- 7 Europe Market Overview
- 7.1 Europe Connected Drug Delivery Devices Market Size by Country
- 7.1.1 Germany Market Overview
- 7.1.2 France Market Overview
- 7.1.3 U.K. Market Overview
- 7.1.4 Italy Market Overview
- 7.1.5 Spain Market Overview
- 7.1.6 Sweden Market Overview
- 7.1.7 Denmark Market Overview
- 7.1.8 Netherlands Market Overview
- 7.1.9 Switzerland Market Overview
- 7.1.10 Belgium Market Overview
- 7.1.11 Russia Market Overview
- 7.2 Europe Connected Drug Delivery Devices Market Size by Type
- 7.3 Europe Connected Drug Delivery Devices Market Size by Application
- 7.4 Top Players in Europe Connected Drug Delivery Devices Market
- 8 Asia-Pacific Market Overview
- 8.1 Asia-Pacific Connected Drug Delivery Devices Market Size by Country
- 8.1.1 China Market Overview
- 8.1.2 Japan Market Overview
- 8.1.3 South Korea Market Overview
- 8.1.4 India Market Overview
- 8.1.5 Australia Market Overview
- 8.1.6 Indonesia Market Overview
- 8.1.7 Malaysia Market Overview
- 8.1.8 Philippines Market Overview
- 8.1.9 Singapore Market Overview
- 8.1.10 Thailand Market Overview
- 8.1.11 Rest of APAC Market Overview
- 8.2 Asia-Pacific Connected Drug Delivery Devices Market Size by Type
- 8.3 Asia-Pacific Connected Drug Delivery Devices Market Size by Application
- 8.4 Top Players in Asia-Pacific Connected Drug Delivery Devices Market
- 9 South America Market Overview
- 9.1 South America Connected Drug Delivery Devices Market Size by Country
- 9.1.1 Brazil Market Overview
- 9.1.2 Argentina Market Overview
- 9.1.3 Columbia Market Overview
- 9.2 South America Connected Drug Delivery Devices Market Size by Type
- 9.3 South America Connected Drug Delivery Devices Market Size by Application
- 9.4 Top Players in South America Connected Drug Delivery Devices Market
- 10 Middle East and Africa Market Overview
- 10.1 Middle East and Africa Connected Drug Delivery Devices Market Size by Country
- 10.1.1 Saudi Arabia Market Overview
- 10.1.2 UAE Market Overview
- 10.1.3 Egypt Market Overview
- 10.1.4 Nigeria Market Overview
- 10.1.5 South Africa Market Overview
- 10.2 Middle East and Africa Connected Drug Delivery Devices Market Size by Type
- 10.3 Middle East and Africa Connected Drug Delivery Devices Market Size by Application
- 10.4 Top Players in Middle East and Africa Connected Drug Delivery Devices Market
- 11 Connected Drug Delivery Devices Market Segmentation by Type
- 11.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 11.2 Global Connected Drug Delivery Devices Sales Market Share by Type (2020-2033)
- 11.3 Global Connected Drug Delivery Devices Market Size Market Share by Type (2020-2033)
- 11.4 Global Connected Drug Delivery Devices Price by Type (2020-2033)
- 12 Connected Drug Delivery Devices Market Segmentation by Application
- 12.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 12.2 Global Connected Drug Delivery Devices Market Sales by Application (2020-2033)
- 12.3 Global Connected Drug Delivery Devices Market Size (M USD) by Application (2020-2033)
- 12.4 Global Connected Drug Delivery Devices Sales Growth Rate by Application (2020-2033)
- 13 Company Profiles
- 13.1 Phillips Medisize
- 13.1.1 Phillips Medisize Company Overview
- 13.1.2 Phillips Medisize Business Overview
- 13.1.3 Phillips Medisize Connected Drug Delivery Devices Major Product Offerings
- 13.1.4 Phillips Medisize Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.1.5 Key News
- 13.2 Bayer AG
- 13.2.1 Bayer AG Company Overview
- 13.2.2 Bayer AG Business Overview
- 13.2.3 Bayer AG Connected Drug Delivery Devices Major Product Offerings
- 13.2.4 Bayer AG Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.2.5 Key News
- 13.3 Kindeva
- 13.3.1 Kindeva Company Overview
- 13.3.2 Kindeva Business Overview
- 13.3.3 Kindeva Connected Drug Delivery Devices Major Product Offerings
- 13.3.4 Kindeva Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.3.5 Key News
- 13.4 Merck KGaA
- 13.4.1 Merck KGaA Company Overview
- 13.4.2 Merck KGaA Business Overview
- 13.4.3 Merck KGaA Connected Drug Delivery Devices Major Product Offerings
- 13.4.4 Merck KGaA Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.4.5 Key News
- 13.5 Propeller Health
- 13.5.1 Propeller Health Company Overview
- 13.5.2 Propeller Health Business Overview
- 13.5.3 Propeller Health Connected Drug Delivery Devices Major Product Offerings
- 13.5.4 Propeller Health Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.5.5 Key News
- 13.6 Sulzer Ltd
- 13.6.1 Sulzer Ltd Company Overview
- 13.6.2 Sulzer Ltd Business Overview
- 13.6.3 Sulzer Ltd Connected Drug Delivery Devices Major Product Offerings
- 13.6.4 Sulzer Ltd Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.6.5 Key News
- 13.7 Biocorp Production SA
- 13.7.1 Biocorp Production SA Company Overview
- 13.7.2 Biocorp Production SA Business Overview
- 13.7.3 Biocorp Production SA Connected Drug Delivery Devices Major Product Offerings
- 13.7.4 Biocorp Production SA Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.7.5 Key News
- 13.8 OPKO Health
- 13.8.1 OPKO Health Company Overview
- 13.8.2 OPKO Health Business Overview
- 13.8.3 OPKO Health Connected Drug Delivery Devices Major Product Offerings
- 13.8.4 OPKO Health Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.8.5 Key News
- 13.9 Cohero Health
- 13.9.1 Cohero Health Company Overview
- 13.9.2 Cohero Health Business Overview
- 13.9.3 Cohero Health Connected Drug Delivery Devices Major Product Offerings
- 13.9.4 Cohero Health Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.9.5 Key News
- 13.10 Elcam Medical
- 13.10.1 Elcam Medical Company Overview
- 13.10.2 Elcam Medical Business Overview
- 13.10.3 Elcam Medical Connected Drug Delivery Devices Major Product Offerings
- 13.10.4 Elcam Medical Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.10.5 Key News
- 13.11 Teva Pharmaceutical Industries Ltd
- 13.11.1 Teva Pharmaceutical Industries Ltd Company Overview
- 13.11.2 Teva Pharmaceutical Industries Ltd Business Overview
- 13.11.3 Teva Pharmaceutical Industries Ltd Connected Drug Delivery Devices Major Product Offerings
- 13.11.4 Teva Pharmaceutical Industries Ltd Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.11.5 Key News
- 13.12 Sagentia (Science Group)
- 13.12.1 Sagentia (Science Group) Company Overview
- 13.12.2 Sagentia (Science Group) Business Overview
- 13.12.3 Sagentia (Science Group) Connected Drug Delivery Devices Major Product Offerings
- 13.12.4 Sagentia (Science Group) Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.12.5 Key News
- 13.13 Proteus Digital Health, Inc
- 13.13.1 Proteus Digital Health, Inc Company Overview
- 13.13.2 Proteus Digital Health, Inc Business Overview
- 13.13.3 Proteus Digital Health, Inc Connected Drug Delivery Devices Major Product Offerings
- 13.13.4 Proteus Digital Health, Inc Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.13.5 Key News
- 13.14 FindAir
- 13.14.1 FindAir Company Overview
- 13.14.2 FindAir Business Overview
- 13.14.3 FindAir Connected Drug Delivery Devices Major Product Offerings
- 13.14.4 FindAir Connected Drug Delivery Devices Sales and Revenue fromConnected Drug Delivery Devices (2020-2025)
- 13.14.5 Key News
- 14 Key Market Trends, Opportunity, Drivers and Restraints
- 14.1 Key Takeway
- 14.2 Market Opportunities & Trends
- 14.3 Market Drivers
- 14.4 Market Restraints
- 14.5 Market Major Factor Assessment
- 14.6 Porter's Five Forces Analysis of Connected Drug Delivery Devices Market
- 14.7 PEST Analysis of Connected Drug Delivery Devices Market
- 15 Analysis of the Connected Drug Delivery Devices Industry Chain
- 15.1 Overview of the Industry Chain
- 15.2 Upstream Segment Analysis
- 15.3 Midstream Segment Analysis
- 15.3.1 Manufacturing, Processing or Conversion Process Analysis
- 15.3.2 Key Technology Analysis
- 15.4 Downstream Segment Analysis
- 15.4.1 Downstream Customer List and Contact Details
- 15.4.2 Customer Concerns or Preference Analysis
- 16 Conclusion
- 17 Appendix
- 17.1 Methodology
- 17.2 Research Process and Data Source
- 17.3 Disclaimer
- 17.4 Note
- 17.5 Examples of Clients
- 17.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
